BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8074017)

  • 1. Transcatheter occlusion of patent ductus arteriosus by Rashkind umbrella device: follow-up results.
    Arora R; Kalra GS; Nigam M; Khalillulah M
    Am Heart J; 1994 Sep; 128(3):539-41. PubMed ID: 8074017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcatheter closure of the patent ductus arteriosus: a comparative study between occluding coils and the Rashkind umbrella device.
    Bulbul ZR; Fahey JT; Doyle TP; Hijazi ZM; Hellenbrand WE
    Cathet Cardiovasc Diagn; 1996 Dec; 39(4):355-63; discussion 364. PubMed ID: 8958423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with 205 procedures of transcatheter closure of ductus arteriosus in 182 patients, with special reference to residual shunts and long-term follow-up.
    Ali Khan MA; al Yousef S; Mullins CE; Sawyer W
    J Thorac Cardiovasc Surg; 1992 Dec; 104(6):1721-7. PubMed ID: 1341428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medium-term follow up of residual shunting and potential complications after transcatheter occlusion of the ductus arteriosus.
    Magee AG; Stumper O; Burns JE; Godman MJ
    Br Heart J; 1994 Jan; 71(1):63-9. PubMed ID: 8297698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevalence of residual shunt after closure of patent ductus arteriosus with Rashkind umbrellas].
    Caixeta AM; Kajita LJ; Rati MA; de Brito Júnior FS; Lima Filho Mde O; Souza AN; Garcia DP; Arie S; Pileggi F
    Arq Bras Cardiol; 1995 Feb; 64(2):121-3. PubMed ID: 7575156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Residual shunt after percutaneous occlusion of patent ductus arteriosus by Rashkind's device. Echographic aspects, outcome, prognostic factors and management].
    Godart F; Rey C; Jarrar M; Francart C; Vaksmann G; Brevière GM
    Arch Mal Coeur Vaiss; 1994 May; 87(5):567-72. PubMed ID: 7857177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-dimensional echocardiographic and color flow Doppler evaluation of ductal occlusion with the Rashkind prosthesis.
    Musewe NN; Benson LN; Smallhorn JF; Freedom RM
    Circulation; 1989 Dec; 80(6):1706-10. PubMed ID: 2598432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcatheter occlusion of the persistently patent ductus arteriosus. Forty-month follow-up and prevalence of residual shunting.
    Hosking MC; Benson LN; Musewe N; Dyck JD; Freedom RM
    Circulation; 1991 Dec; 84(6):2313-7. PubMed ID: 1959187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A comparative study of Rashkind, Grifka and coil devices in percutaneous closing of patent ductus arteriosus].
    Lázaro Castillo JL; Munayer Calderón J; Aldana Pérez T; San Luis Miranda R; Maza Juárez G; Ramírez Reyes H; Arias Monroy L; Campos Gómez A; Amaya Hernández A
    Arch Inst Cardiol Mex; 2000; 70(2):167-72. PubMed ID: 10932802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Patent ductal arteriosus occlusion by Rashkind umbrella and by detachable coil].
    Mahayni MN; Pépin-Donat M; Saillant D; Poinsot J; Vaillant MC; Chantepie A
    Arch Mal Coeur Vaiss; 2002 May; 95(5):418-24. PubMed ID: 12085739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catheter occlusion of the persistently patent ductus arteriosus.
    Dyck JD; Benson LN; Smallhorn JF; McLaughlin PR; Freedom RM; Rowe RD
    Am J Cardiol; 1988 Nov; 62(16):1089-92. PubMed ID: 3189172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of surgical ligation of patent ductus arteriosus in the era of the Rashkind device.
    Galal O; Nehgme R; al-Fadley F; de Moor M; Abbag FI; al-Oufi SH; Williams E; Fawzy ME; al-Halees Z
    Ann Thorac Surg; 1997 Feb; 63(2):434-7. PubMed ID: 9033315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcatheter closure of the patent ductus arteriosus with new-generation devices: comparative data and follow-up results.
    Donti A; Formigari R; Bonvicini M; Prandstraller D; Bronzetti G; Picchio FM
    Ital Heart J; 2002 Feb; 3(2):122-7. PubMed ID: 11926010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Closure of patent ductus arteriosus using interventional catheterization].
    Verin V; Friedli B; Oberhänsli I; Urban P; Meier B
    Schweiz Med Wochenschr; 1993 Mar; 123(12):530-2. PubMed ID: 8475359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcatheter management of residual shunts after initial transcatheter closure of a patent arterial duct.
    Ovaert C; McCrindle BW; Nykanen D; Freedom RM; Benson LN
    Can J Cardiol; 2003 Dec; 19(13):1493-7. PubMed ID: 14760439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcatheter patent ductus arteriosus occlusion: application in the small child.
    Nykanen DG; Hayes AM; Benson LN; Freedom RM
    J Am Coll Cardiol; 1994 Jun; 23(7):1666-70. PubMed ID: 8195529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reocclusion for persistent shunting after catheter placement of the Rashkind patent ductus arteriosus occluder.
    Hosking MC; Benson LN; Musewe N; Freedom RM
    Can J Cardiol; 1989 Oct; 5(7):340-2. PubMed ID: 2531029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcatheter closure of a large patent ductus arteriosus with the clamshell septal umbrella.
    Bridges ND; Perry SB; Parness I; Keane JF; Lock JE
    J Am Coll Cardiol; 1991 Nov; 18(5):1297-302. PubMed ID: 1918707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcatheter closure in 354 pediatric cases of patent ductus arteriosus using five different devices.
    Zhang Z; Qian M; Wang H; Li Y
    Chin Med J (Engl); 2001 May; 114(5):456-8. PubMed ID: 11780402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcatheter closure of patent ductus arteriosus in children and adults.
    Wilson NJ; Neutze JM; Mawson JB; Calder AL
    N Z Med J; 1993 Jul; 106(960):299-301. PubMed ID: 8341451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.